Oliver Schnell

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Cardiovascular Disease

Top Venues

Journal of diabetes science and technology

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

Diabetes technology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Oliver Schnell, Ralph Ziegler
The Promise of Hypoglycemia Risk Prediction. Journal of diabetes science and technology (2024)
Oliver Schnell, Ralph Ziegler
The Promise of Hypoglycemia Risk Prediction. Journal of diabetes science and technology 18 (5) (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Oliver Schnell, Ralph Ziegler
The Promise of Hypoglycemia Risk Prediction. Journal of diabetes science and technology 18 (5) (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism (2024)
Matthias Blüher, Mohini Aras, Louis J Aronne, Rachel L Batterham, Francesco Giorgino, Li-Nong Ji, Kirsi H Pietiläinen, Oliver Schnell, Elena Tonchevska, John P H Wilding
New insights into the treatment of obesity. Diabetes, obesity & metabolism (2023)
Francesco Giorgino, Tadej Battelino, Richard M Bergenstal, Thomas Forst, Jennifer B Green, Chantal Mathieu, Helena W Rodbard, Oliver Schnell, Emma G Wilmot
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of diabetes science and technology (2023)
Mike Grady, Hilary Cameron, Amey Bhatiker, Elizabeth Holt, Oliver Schnell
Real-World Evidence of Improved Glycemic Control in People with Diabetes Using a Bluetooth-Connected Blood Glucose Meter with a Mobile Diabetes Management App. Diabetes technology & therapeutics 24 (10) (2022)
Christoph Wanner, Paola Fioretto, Csaba P Kovesdy, Jolanta Malyszko, Roberto Pecoits-Filho, Oliver Schnell, Patrick Rossignol
Potassium management with finerenone: Practical aspects. Endocrinology, diabetes & metabolism (2022)
Christoph Wanner, Paola Fioretto, Csaba P Kovesdy, Jolanta Malyszko, Roberto Pecoits-Filho, Oliver Schnell, Patrick Rossignol
Potassium management with finerenone: Practical aspects. Endocrinology, diabetes & metabolism (2022)
Lutz Heinemann, Melanie Davies, Philip Home, Thomas Forst, Tina Vilsbøll, Oliver Schnell
Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials. Journal of diabetes science and technology (2022)
Tadej Battelino, Frank Brosius, Antonio Ceriello, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T Prashant Nedungadi, Lars Rydén, Helena W Rodbard, Li-Nong Ji, Wayne Huey-Herng Sheu, Eberhard Standl, Christopher G Parkin, Oliver Schnell
Guideline Development for Medical Device Technology: Issues for Consideration. Journal of diabetes science and technology (2022)
Lutz Heinemann, Oliver Schnell, Bernhard Gehr, Nanette C Schloot, Sven W Görgens, Christoph Görgen
Digital Diabetes Management: A Literature Review of Smart Insulin Pens. Journal of diabetes science and technology (2021)
Bernd Schultes, Susanne Emmerich, Andreas D Kistler, Badreddine Mecheri, Oliver Schnell, Gottfried Rudofsky
Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease. Journal of diabetes science and technology (2021)
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes. Cardiovascular diabetology 20 (1) (2021)
Antonio Ceriello, Oliver Schnell
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management. Journal of diabetes science and technology 14 (4) (2020)
Juliette Agnah, Katharina Fritzen, Larisa Popovich, Svetlana Svetlichnaya, Yasser Hosny, Haik Aleksanyan, Alexander Moiseev, Joyce Van Hoek, Oliver Schnell
Potential Cost Savings for the Healthcare System of the Russian Federation Through the Utilization of a Blood Glucose Meter With Color Range Indicator. Journal of diabetes science and technology 15 (1) (2020)
Guido Freckmann, Sina Buck, Delia Waldenmaier, Bernhard Kulzer, Oliver Schnell, Ulrich Gelchsheimer, Ralph Ziegler, Lutz Heinemann
Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies. Journal of diabetes science and technology 15 (4) (2020)
Stephan Kress, Helmut Anderten, Anja Borck, Guido Freckmann, Lutz Heinemann, Ulrike Holzmüller, Bernhard Kulzer, Alexandra Portele, Oliver Schnell, Helga Varlemann, Claudia Zemmrich, Ralf Lobmann
Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score. Journal of diabetes science and technology 15 (4) (2020)
Oliver Schnell, Paul Valensi, Eberhard Standl, Antonio Ceriello
Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes. Endocrinology, diabetes & metabolism 3 (3) (2020)
Mike Grady, Usha Venugopal, Katia Robert, Graham Hurrell, Oliver Schnell
Health Care Professionals' Clinical Perspectives and Acceptance of a Blood Glucose Meter and Mobile App Featuring a Dynamic Color Range Indicator and Blood Sugar Mentor: Online Evaluation in Seven Countries. JMIR human factors 6 (3) (2019)
Katharina Fritzen, Kornelia Basinska, Constantin Stautner, Karl F Braun, Matilde Rubio-Almanza, Antonio Nicolucci, Brian Kennon, Bruno Vergès, Yasser Hosny, Oliver Schnell
Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems. Journal of diabetes science and technology 14 (2) (2019)